[25] Eligible patients had resistance to two or more classes of antiretroviral drugs ... with raltegravir. Dolutegravir also outperformed raltegravir in those patients with HIV viral loads ...

Lenacapavir has shown high efficacy in managing multidrug-resistant cases, offering hope to patients with limited alternatives. A significant breakthrough in treating the Human Immunodeficiency ...

Dolutegravir is an HIV integrase strand transfer inhibitor ... noninferiority when compared with first-generation HIV INSTI raltegravir. For treatment-experienced patients dolutegravir ...

If left untreated, human immunodeficiency virus (HIV) almost always will progress to AIDS, even after many years. The immune defenses become compromised and the body is less able to defend itself ...

This product would be manufactured at the drug firm's Nagpur facility and will be supplied to low-and middle-income countries, it said. The fixed-dose combination of Abacavir 60 mg/Dolutegravir 5 ...

If you take medications to treat HIV, some of those can also cause HIV rashes. Most HIV rashes aren't serious and will typically clear up in a few days to a few weeks, even without treatment.

A new report has shed light on the struggles of HIV-positive Palestinians living in Gaza, where medication is running out. Queer HIV-positive Palestinians living in the Gaza Strip have revealed the ...

Antiretroviral therapy, first introduced with the FDA’s approval of AZT in 1987, was a turning point in HIV treatment. Over 50 antiretroviral drugs are now FDA-approved, offering a range of ...

Eight patients completed the full duration of the study with four of them showing a reduction in total HIV DNA ranging from 2% to 85%, and four patients experienced an increase of viral load ...

With Israel‘s war with Hamas in Gaza remaining ongoing and a ceasefire talks only just beginning, access to life-saving HIV medications in Gaza has all but disappeared. An investigative report ...